- United States
- /
- Medical Equipment
- /
- NYSE:ITGR
Integer Holdings (ITGR): $69.6M One-Off Loss Challenges Margin Recovery Narrative
Reviewed by Simply Wall St
Integer Holdings (ITGR) posted headline earnings with profit margins narrowing to 4.8% over the last twelve months, down from 6.9% a year earlier, as a significant one-time loss of $69.6 million weighed on performance. While revenue is forecast to rise at 3.8% per year, which lags the broader US market’s 10% expectation, analysts are projecting robust EPS growth of 35.7% per year despite these recent setbacks.
See our full analysis for Integer Holdings.With the numbers on the table, it's time to see how the latest earnings stack up against the ongoing narratives to assess where expectations hold up and where the story might be changing.
See what the community is saying about Integer Holdings
Margins Lag Peers Despite Operating Improvements
- Profit margins are sitting at 4.8%, which is not only lower than last year’s 6.9% but is well below analysts’ expectation for a future expansion to 13.9% by 2028.
- According to the analysts' consensus view, Integer’s margin pressure today stands in contrast to ongoing operational improvements, such as manufacturing automation and efficiency upgrades, claimed in the consensus narrative.
- While recent investments are boosting gross and operating margins quarter to quarter, the step down in net margin from the prior year challenges the narrative that profit expansion is already materializing.
- Consensus notes that margin gains are seen as critical for justifying expected earnings growth. The current compression raises the stakes for these operational initiatives to deliver results in the coming quarters.
- For a closer look at how Integer’s latest margin figures stack up against narrative optimism, see the full consensus case for investors. 📊 Read the full Integer Holdings Consensus Narrative.
One-Off Loss Skews Reported Profitability
- A $69.6 million one-time charge weighed on Integer’s annual results, driving down net margins and complicating the true year-on-year earnings trend versus the company’s five-year average earnings growth of 5% per annum.
- Consensus narrative highlights that while outperformance in Q2 was partly a result of inventory pull-forward, a temporary boost, higher volatility from one-off items and customer demand timing could mean recent headline numbers overstate underlying growth.
- Critics note that customer concentration and product attrition offset growth drivers, and around 70% of revenue relies on large OEM contracts, which could amplify swings if a customer pulls back or renegotiates terms.
- What is surprising is that, even with these risks, analysts are still modeling robust annual EPS growth of 35.7%, showing confidence in future recovery, but this estimate faces headwinds if such one-offs persist or become recurring.
Shares Trade Below DCF Fair Value Despite Sector Discount
- Integer’s share price of $72.91 is below both its DCF fair value of $82.16 and the analyst price target ($86.00), and trades at a 29.3x P/E, at a discount to direct peers (44.8x) and the US Medical Equipment industry average (30.3x).
- Consensus narrative argues that this undervaluation relative to peers and fair value, paired with sector tailwinds in high-growth medtech markets, could attract investors willing to look past near-term earnings volatility.
- Bulls see the discounted valuation as a chance to buy ahead of margin and EPS expansion promised by operational improvements and new product launches.
- Skeptics counter that, unless Integer can prove margin durability and mitigate risks from concentrated customers and FX volatility, this discount may persist or widen.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Integer Holdings on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
Do the figures point you in a new direction? Quickly craft your unique take on the story and make your perspective count. Do it your way.
A great starting point for your Integer Holdings research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
See What Else Is Out There
Integer Holdings’ compressed profit margins and reliance on one-off items highlight its struggle to deliver consistent and stable growth amid operational and customer risks.
If you want more reliable performance and steadier expansion, check out stable growth stocks screener (2099 results) for companies that consistently post solid results year after year, even when others falter.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Mobile Infrastructure for Defense and Disaster
The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.
Get the investor briefing before the next round of contracts
Sponsored On Behalf of CiTechNew: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:ITGR
Integer Holdings
Operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally.
Good value with moderate growth potential.
Similar Companies
Market Insights
Weekly Picks
Early mover in a fast growing industry. Likely to experience share price volatility as they scale

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08
Recently Updated Narratives
Airbnb Stock: Platform Growth in a World of Saturation and Scrutiny
Clarivate Stock: When Data Becomes the Backbone of Innovation and Law
Adobe Stock: AI-Fueled ARR Growth Pushes Guidance Higher, But Cost Pressures Loom
Popular Narratives

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
